FENC stock pitch - 2022-06-30

Added to YB: 2022-06-30

Pitch date: 2022-06-30

Fennec Pharmaceuticals Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States.

Market Cap

$287.6M

Pitch Price

$5.67

Price Target

N/A

Dividend

N/A

EV/EBITDA

-65.87

P/E

-32.15

EV/Sales

7.35

Sector

Biotechnology

A summary for this pitch has not been created yet.